|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Depreciation and amortization | |||||
| Impairment expense | |||||
| Common stock issued for services | |||||
| Bad debt expense | |||||
| Amortization of debt discount | |||||
| Conversion fees | |||||
| Stock compensation expenses | |||||
| Net unrealized exchange gain | |||||
| Expenses settled through equity | |||||
| Interest expense | |||||
| Other income | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Other current assets | |||||
| Due from related party | |||||
| Advances | |||||
| Accounts payable and accrued expenses | |||||
| Other current liabilities | |||||
| Contingent consideration | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of furniture and equipment | |||||
| Acquisition of intangible assets | |||||
| Increase in other non-current assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Stock options exercised | |||||
| Increase in capital | |||||
| Proceeds from / (Repayment of) short term borrowing | |||||
| Proceeds from sale of common stock | |||||
| Proceeds from equity issuance | |||||
| Interest paid | |||||
| Net cash provided by financing activities | |||||
| Net increase/(decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the period | |||||
| Cash and cash equivalents at the end of the period | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Cash and cash equivalents at the end of the year | |||||
| Supplementary disclosure of cash flows information | |||||
| Interest | |||||
| Income taxes | |||||
| Income tax | |||||
| Contingent consideration settled with common stock | |||||
| Relative fair value of warrants issued with convertible debt | |||||
| Conversion of debt for common stock | |||||
| Conversion of debt to common stock | |||||
| Settlement of contingent consideration | |||||
| Common stock issued for acquisition | |||||
| Issuance of Series B preferred stock in connection with acquisition of customer contracts from a common control entity | |||||
Loading...